VTYX — Ventyx Biosciences Share News
0.000.00%
Last trade - 00:00Ventyx Biosciences soars as report says Eli Lilly eyes $1 billion acquisition
Press Digest: Wall Street Journal - January 7
Lilly in talks to buy Ventyx Biosciences for more than $1 billion, WSJ reports (updated)
NASDAQ RESUMED AT 04:00 PM
Lilly in talks to buy Ventyx Biosciences in more than $1 billion deal, WSJ reports
Brief: Eli Lilly In Advanced Talks To Buy Ventyx Biosciences For Over $1 Billion - WSJ
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:40 PM
Brief: Ventyx Provides Clinical And Corporate Updates
Ventyx Biosciences Q3 net loss narrows to $22.8 mln
Brief: Ventyx Biosciences Q3 EPS USD -0.32
U.S. STOCKS ON THE MOVE-LendingClub, Hasbro, Intel
U.S. STOCKS ON THE MOVE-Lam Research, Rivian Automotive, Eli Lilly
Ventyx set for record day as oral drug reduces heart disease risk markers in trial
U.S. STOCKS ON THE MOVE-Blackstone, Darling Ingredients, Harmony Biosciences
U.S. STOCKS ON THE MOVE-Ventyx Biosciences, Dow, Las Vegas
Ventyx jumps as oral drug reduces heart disease risk markers in mid-stage trial
Brief: Ventyx Biosciences Announces Positive Topline Results From Phase 2 Study Of Vtx3232 In Participants With Obesity And Cardiovascular Risk Factors
Ventyx Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Ventyx Biosciences Q2 EPS USD -0.38 Vs. IBES Estimate USD -0.47